Cloud Inspection Medicine announced the completion of the B1 round of financing

"Science and Technology Board Daily" reported on the 19th that the Cloud Inspection Medical Group (hereinafter referred to as "Cloud Inspection Medicine") received the exclusive investment of the Astraikan CICC Medical Industry Fund. This round of financing is mainly used to further expand the company's maternal and child product line and cancer testing product research and development pipeline, and continue to promote the development, commercialization of commercialization, commercialization and international markets of various product lines in China and the United States.

According to smart bud data, there are currently more than 20 patent applications of cloud inspection medicine and its related companies, of which more than 10 invention patents are invention. The company's patent layout mainly focuses on related fields such as kits and metabolic groups.

According to the company's information, the establishment of Yunqi Medicine in 2015 is a leading company in the field of precision medical care. It focuses on the research and application of multi -group, artificial intelligence, and medical big data. Deliven the application, diagnosis and treatment of innovative multiple groups and artificial intelligence technology and diseases, providing early screening, medication guidance, recurrence monitoring, and new tumor research and development of chronic diseases and cancer. The company's science and technology team comes from the biological research and development team of Stanford's medical education background. It has rich experience in multi -group and artificial intelligence clinical research and transformation research experience. It is reported that Yunqi Medicine is currently with Zhejiang University, Fudan University, Shanghai Ruijin Hospital, Sichuan University Huaxi Hospital, Shanghai Cancer Hospital, China Disease Prevention and Control Center, Taiwan Chang Geng Hospital, Hong Kong Santa Mary Hospital, Berkshire Medical System, USA San Joseph Hospital, InternetSystems, Stanford and many other well -known universities and hospitals at home and abroad have launched cooperation.

At present, Yunqi Medicine has established or cooperative medical laboratories and operating centers in Shanghai, Tianjin, Hangzhou, Nanjing, Chengdu, Hong Kong and other places to provide accurate intelligent services for many domestic and foreign hospitals and health institutions. And the industrial development of smart medical care. It is reported that Yunqi Medicine is currently with Zhejiang University, Fudan University, Shanghai Ruijin Hospital, Sichuan University Huaxi Hospital, Shanghai Cancer Hospital, China Disease Prevention and Control Center, Taiwan Chang Geng Hospital, Hong Kong Santa Mary Hospital, Berkshire Medical System, USA San Joseph Hospital, InternetSystems, Stanford and many other well -known universities and hospitals at home and abroad have launched cooperation. The products and platforms of the company include major chronic diseases with intelligent early screening, precision medication of tumor, analysis of smart big data, and high -resolution platforms.

- END -